Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy and Safety of an Oral Growth Hormone Drug in the Treatment of Fibromyalgia

This study has been completed.
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Robert Bennett MD, Bennett, Robert, M.D.
ClinicalTrials.gov Identifier:
NCT00116129
First received: June 27, 2005
Last updated: August 2, 2012
Last verified: August 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2008
  Primary Completion Date: January 2008 (Final data collection date for primary outcome measure)